Literature DB >> 7979273

Mechanisms of high-level resistance to quinolones in urinary tract isolates of Pseudomonas aeruginosa.

T Yoshida1, T Muratani, S Iyobe, S Mitsuhashi.   

Abstract

Twenty-eight strains of Pseudomonas aeruginosa with various degrees of norfloxacin resistance were isolated from patients with urinary tract infections. P. aeruginosa strains (norfloxacin MICs, 3.13 to 200 micrograms/ml) were transformed by either pPAW207 or pNF111 plasmid DNA, which included either the gyrA or nfxB gene, respectively. For transformants with pPAW207, norfloxacin MICs decreased 8- to 128-fold. It was suggested that moderate and high degrees of resistance to norfloxacin were expressed as a result of alterations in gyrA. No strain manifesting only an alteration in nfxB permeability was observed. The MICs of norfloxacin (200 micrograms/ml) for two P. aeruginosa strains, GN17605 and GN17434-2, were decreased following transformation not only by pPAW207 but also by pNF111. Analysis of outer membrane proteins disclosed the presence of a 54,000-Da protein in these parent strains that was not expressed in the pNF111 transformants. The level of accumulation of norfloxacin by the pNF111 transformant of GN17605 was higher than that by the parent strain. The norfloxacin susceptibility of DNA gyrase subunit A purified from GN17605 was only 1/35th that of the gyrase containing a subunit A from P. aeruginosa PAO1. These findings suggest that GN17605 is a gyrA-nfxB double mutant and that strain GN17434-2 possesses double mutations in both nfxB and some unknown gene.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7979273      PMCID: PMC284577          DOI: 10.1128/AAC.38.7.1466

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  Cloning and characterization of a DNA fragment that complements the nfxB mutation in Pseudomonas aeruginosa PAO.

Authors:  T Okazaki; S Iyobe; H Hashimoto; K Hirai
Journal:  FEMS Microbiol Lett       Date:  1991-03-15       Impact factor: 2.742

2.  Lipopolysaccharide alterations responsible for combined quinolone and beta-lactam resistance in Pseudomonas aeruginosa.

Authors:  H J Leying; K H Büscher; W Cullmann; R L Then
Journal:  Chemotherapy       Date:  1992       Impact factor: 2.544

3.  Proportion of DNA gyrase mutants among quinolone-resistant strains of Pseudomonas aeruginosa.

Authors:  H Yoshida; M Nakamura; M Bogaki; S Nakamura
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

4.  Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli.

Authors:  H Yoshida; M Bogaki; M Nakamura; S Nakamura
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

5.  In vitro activity of OPC-17116.

Authors:  H C Neu; W Fang; J W Gu; N X Chin
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

6.  The in-vitro activity of Bay y 3118, a new chlorofluoroquinolone.

Authors:  R Wise; J M Andrews; N Brenwald
Journal:  J Antimicrob Chemother       Date:  1993-01       Impact factor: 5.790

7.  Plasmid-mediated gentamicin resistance of Pseudomonas aeruginosa and its lack of expression in Escherichia coli.

Authors:  T Kato; Y Sato; S Iyobe; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

8.  In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents.

Authors:  R Wise; J M Andrews; L J Edwards
Journal:  Antimicrob Agents Chemother       Date:  1983-04       Impact factor: 5.191

9.  Occurrence of the nfxB type mutation in clinical isolates of Pseudomonas aeruginosa.

Authors:  E B Jakics; S Iyobe; K Hirai; H Fukuda; H Hashimoto
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

10.  Broad-host-range gyrase A gene probe.

Authors:  N J Robillard
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

View more
  18 in total

Review 1.  Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria.

Authors:  K Poole
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

2.  A dose-response study of antibiotic resistance in Pseudomonas aeruginosa biofilms.

Authors:  A Brooun; S Liu; K Lewis
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

3.  Pharmacodynamics of levofloxacin against Pseudomonas aeruginosa with reduced susceptibility due to different efflux pumps: do elevated MICs always predict reduced in vivo efficacy?

Authors:  David C Griffith; Erik Corcoran; Denene Lofland; Angela Lee; Deidre Cho; Olga Lomovskaya; Michael N Dudley
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

4.  Overexpression of MexCD-OprJ reduces Pseudomonas aeruginosa virulence by increasing its susceptibility to complement-mediated killing.

Authors:  Inmaculada Martínez-Ramos; Xavier Mulet; Bartolomé Moyá; Mariette Barbier; Antonio Oliver; Sebastián Albertí
Journal:  Antimicrob Agents Chemother       Date:  2014-01-13       Impact factor: 5.191

5.  Differential selection of multidrug efflux systems by quinolones in Pseudomonas aeruginosa.

Authors:  T Köhler; M Michea-Hamzehpour; P Plesiat; A L Kahr; J C Pechere
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

6.  Use of a genetic approach to evaluate the consequences of inhibition of efflux pumps in Pseudomonas aeruginosa.

Authors:  O Lomovskaya; A Lee; K Hoshino; H Ishida; A Mistry; M S Warren; E Boyer; S Chamberland; V J Lee
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

7.  Relationship between outer membrane protein profiles and resistance to ceftazidime, imipenem, and ciprofloxacin in Pseudomonas aeruginosa isolates from bacteremic patients.

Authors:  C Gimeno; D Navarro; F Savall; E Millás; M A Farga; J Garau; R Cisterna; J García-de-Lomas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-01       Impact factor: 3.267

8.  Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump.

Authors:  Katy Jeannot; Sylvie Elsen; Thilo Köhler; Ina Attree; Christian van Delden; Patrick Plésiat
Journal:  Antimicrob Agents Chemother       Date:  2008-05-12       Impact factor: 5.191

9.  MexCD-OprJ multidrug efflux system of Pseudomonas aeruginosa: involvement in chlorhexidine resistance and induction by membrane-damaging agents dependent upon the AlgU stress response sigma factor.

Authors:  Sebastien Fraud; Aaron J Campigotto; Zhilin Chen; Keith Poole
Journal:  Antimicrob Agents Chemother       Date:  2008-10-06       Impact factor: 5.191

10.  In vivo emergence of multidrug-resistant mutants of Pseudomonas aeruginosa overexpressing the active efflux system MexA-MexB-OprM.

Authors:  I Ziha-Zarifi; C Llanes; T Köhler; J C Pechere; P Plesiat
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.